Average Co-Inventor Count = 1.39
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rosalind Franklin University of Medicine and Science (13 from 48 patents)
2. Ionis Pharmaceuticals, Inc. (3 from 270 patents)
3. The Mclean Hospital Corporation (3 from 123 patents)
4. Hastings, Michelle L. (0 patent)
13 patents:
1. 12042508 - Antisense compounds targeting genes associated with cystic fibrosis
2. 11732260 - Compounds and methods for the modulation of amyloid-β precursor protein
3. 11116785 - Antisense compounds targeting genes associated with cystic fibrosis
4. 10787669 - Antisense compounds targeting Leucine-Rich repeat kinase 2(LRRK2) for the treatment of Parkinsons disease
5. 10544417 - Antisense compounds targeting genes associated with cystic fibrosis
6. 10525076 - Antisense compounds targeting genes associated with cystic fibrosis
7. 10472634 - Antisense compounds targeting apolipoprotein E receptor 2
8. 10370667 - Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease
9. 9840709 - Antisense compounds targeting genes associated with cystic fibrosis
10. 9840710 - Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease
11. 9556434 - Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for usher syndrome
12. 9353371 - Antisense compounds targeting genes associated with usher syndrome
13. 8648053 - Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for Usher syndrome